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GAN1 and Keap1 are proteins characterized by a N-terminal BTB domain and a C-
terminal Kelch repeat domain. Both of these domains are protein-protein 
interaction domains, suggesting that these BTB-Kelch proteins form signaling 
complexes in cells. Previous work has suggested that BTB-Kelch proteins 
function as substrate adaptor proteins for Cul3-dependent E3 ubiquitin ligase 
complexes. The goal of this project was to identify substrate proteins of 
GAN1 and Keap1. This information will be particularly useful when for 
understanding Giant Axonal Neuropathy, a sensorimotor disease characterized 
by excessive accumulation of neurofilaments in neurons that contain mutated 
GAN1 genes. We used an affinity purification approach to identify candidate 
substrate proteins for GAN1 and Keap1. Recombinant GAN1 and Keap1 genes 
containing a C-terminal chitin binding domain (CBD) were inserted into pBabe 
puro vectors. These vectors were used to generate virus stocks, which were 
used to infect a microglial cell line, BV-2. Stable cell lines were generated 
using puromycin selection. A mock-infected cell line was generated in 
parallel. When the cell lines were confluent, the cells were lysed using a 
0.1% SDS RIPA solution and chitin beads were used to precipitate the CBD-
tagged proteins. Western blot analyses were performed to determine if the 
purification of the CBD-tagged proteins was successful. No CBD-tagged 
proteins were identified in our first pull-down experiment. We are currently 
reexamining the precipitation protocol and preparing to lysate the same set 
of cells. 
 
